Invesco QQQ Trust | - | 38.23% | - | - | 102,178 |
State Street® SPDR® S&P® Biotech ETF | - | 20.55% | - | - | 266,778 |
iShares US Pharmaceuticals ETF | - | 15.80% | - | - | 284,986 |
FT Vest Gold Strategy Trgt Inc ETF | - | 15.11% | - | - | 901,645 |
iShares Core S&P Total US Stock Mkt ETF | - | 9.76% | - | - | 105,272 |
WisdomTree Bloomberg US Dllr Bullish ETF | - | 0.00% | - | - | 0 |
Vanguard Short-Term Treasury ETF | - | 0.00% | - | - | 0 |
iShares Gold Strategy ETF | - | 0.00% | - | - | 0 |
iShares® 0-3 Month Treasury Bond ETF | - | 0.00% | - | - | 0 |
ETF Series Solutions - McElhenny Sheffield Managed Risk ETF is an exchange traded fund launched by ETF Series Solutions. The fund is co-managed by Aptus Capital Advisors, LLC and McElhenny Sheffield Capital Management, LLC. It invests in public equity, fixed income, commodity and currency markets of the United States. For its equity portion, the fund invests through other funds in stocks of companies operating across diversified sectors. It invests in growth and value stocks of companies across diversified market capitalization. For its fixed income portion, the fund invests through other funds in investment-grade bonds issued by the U.S. government or its agencies or instrumentalities or by corporations. It invests in fixed income securities of varying maturities. For its commodity portion, the fund invests through other funds in physical gold or products backed by or linked to physical gold. For its currency portion, the fund invests in other funds that seek exposure to the U.S. dollar relative to a basket of foreign currencies. The fund seeks to benchmark the performance of its portfolio againsta composite index comprising of 60% S&P 500 TR Index and 40% Bloomberg US Aggregate Bond Index. It employs proprietary research to create its portfolio. ETF Series Solutions - McElhenny Sheffield Managed Risk ETF was formed on November 16, 2021 and is domiciled in the United States.